-+ 0.00%
-+ 0.00%
-+ 0.00%

ADALTA - FDA ASSIGNS ORPHAN DRUG DESIGNATION FOR EW-001 IN MESOTHELIOMA TO ADALTA

Reuters·11/16/2026 21:29:19

Please log in to view news